Algo version: 0.98b
Abnova (Taiwan) is listed at the TAI Exchange
Abnova (Taiwan) [4133.TW]
TAI Sector: Healthcare Industry:Biotechnology

Is Abnova (Taiwan) stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Abnova (Taiwan) pays dividends. Last time was Thursday 27th of June 2024 where the investors holding the stock on Thursday 6th of June 2024 were paid TWD0.72 per share. Over the last 16 times between 2010 and 2024, Abnova (Taiwan) has paid TWD14.53929 with an average of TWD0.91 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Abnova (Taiwan) 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was TWD28.30, you would have made a profit of TWD1.900 per share or 6.71%

Yes, the average daily trading liquidity for Abnova (Taiwan) is TWD247 674 thousand. You should therefore be able to get in and out of your positions relatively fast.

Abnova (Taiwan) has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 8.00, the company's ability to pay off the debt is good. Abnova (Taiwan) has a good net profit margin of 16.06% and should have high tolerances against inflation.

We have calculated the inflation risk for Abnova (Taiwan) to be low [0.1 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.